Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-230467

Chief Executive Officer sold 40,000 shares at an average $85.08 ($3,403,253)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BELANOFF JOSEPH K · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-01 Sale : show line 1 in the form 10b5-1 −5,616 $84.29 $473,370 2,815,754 I
2025-10-01 Sale : show line 2 in the form 10b5-1 −31,190 $85.16 $2,656,265 2,784,564 I
2025-10-01 Sale : show line 3 in the form 10b5-1 −3,194 $85.67 $273,618 2,781,370 I
Open-market sales · 40,000 sh · avg $85.08 · $3,403,253
Loading xslF345X05/ownership.xml…